Skip to main content
Top

Clinical and Translational Oncology

Issue 2/2009

Content (12 Articles)

Editorial

Colorectal cancer prevention

Montse Andreu, Mercè Marzo, Juanjo Mascort, Enrique Quintero, Pilar García-Alfonso, Cristina López-Ibor, Toni Castells, Pedro Pérez Segura

News and Views

We keep on working

Enrique García Jordá

Educational Series

When neighbourhood matters: tumour microenvironment

Mirna Pérez-Moreno

Educational Series

Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy

Gretel Chometon, Verena Jendrossek

Educational Series

Predictive modelling in hormone-refractory prostate cancer (HRPC)

Joaquim Bellmunt, Joan Carles, Joan Albanell

Special Article

Professional burnout among Spanish medical oncologists

Carlos Camps, Yolanda Escobar, Emilio Esteban, José Alfredo Almenárez, Bernardo Moreno Jiménez, Macarena Gálvez Herrer, Pilar Arranz, Pedro T. Sánchez

Research Articles

Sternal resection and reconstruction after malignant tumours

José M. Galbis Caravajal, Luis Yeste Sánchez, Carlos A. Fuster Diana, Ricardo Guijarro Jorge, Paula Fernández Ortiz, Pam J. Deaville

Research Articles

Female breast cancer in Gipuzkoa: prognostic factors and survival

Nerea Larrañaga, Cristina Sarasqueta, Pablo Martínez-Camblor, M. Jesús Mitxelena, Arantza Mendiola, Iñaki Martínez-Pueyo, Mikel Basterretxea

Research Articles

Heterotopic ossification after total hip arthroplasty (THA) in congenital hip disease: comparison of two different prophylactic protocols

Emilios E. Pakos, Kosmas S. Stafilas, Aggelos N. Politis, Pericles G. Tsekeris, Gregory Mitsionis, Theodore A. Xenakis

Research Articles

Evaluation of toxicity of surgery and/or chemoirradiation treatment of uterine cervix cancer

Vicente Tormo Ferrero, Francisco J. Andreu Martínez, Rafael Cardenal Maciá

Case Reports

Extravasation of oxaliplatin: an infrequent and irritant toxicity

Carles Pericay, Anna López, Joan Ramón Soler, Teresa Bonfill, Emma Dotor, Eugeni Saigí

Case Reports

Metastasis to the nasal cavity from primary rectal adenocarcinoma

Carlos Conill, Mauricio Vargas, Izaskun Valduvieco, Pedro L. Fernández, Antonio Cardesa, Sebastián Capurro

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine